Physician profile

Jared D Gunnell

Physician Assistant · Mesa, AZ

NPI 1366791873

$3,352.23

in general payments reported to CMS, 2019-2025

41 companies · $809 in 2025

The $809 reported for 2025 was more than what 80% of Physician Assistant providers received nationally (typical 2025 total: $183).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$1,909.02

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Abbvie INC. $376.79 2021-2025
Abbott Laboratories $314.05 2021-2025 Freestyle Libre 3, Freestyle Libre 2, Proclaim
Lilly USA, LLC $218.08 2022-2025 Mounjaro, Jardiance, Zepbound
Novo Nordisk INC $197.51 2022-2025 Ozempic, Rybelsus, Wegovy
Boehringer Ingelheim Pharmaceuticals, INC. $173.08 2021-2024 Jardiance
Janssen Pharmaceuticals, INC $167.17 2021-2024 Spravato, Xarelto
Glaxosmithkline, LLC. $156.52 2021-2025 Trelegy Ellipta, Arexvy, Shingrix
Mylan Specialty L.P. $135.13 2021-2024 Yupelri
Inspire Medical Systems, INC. $134.96 2025 Inspire
Pfizer INC. $123.45 2021-2025
Merck Sharp & Dohme LLC $98.85 2021-2025 Gardasil 9, Capvaxive, Gardasil
Astellas Pharma US INC $98.58 2021-2025 Veozah
Amgen INC. $96.59 2022-2024 Prolia, Evenity, Repatha
Astrazeneca Pharmaceuticals LP $94.90 2021-2025 Airsupra
Axsome Therapeutics, INC. $80.94 2024-2025 Sunosi
Show all 41 companies
CompanyGeneral paymentsYearsTop products
Lucid Diagnostics INC. $75.87 2021-2022
Sanofi-Aventis U.S. LLC $74.61 2022-2024
Dexcom, INC. $66.69 2024-2025 Dexcom G6 Transmitter
Exact Sciences Corporation $61.17 2024 Cologuard Collection Kit
Salix Pharmaceuticals, A Division of Bausch Health US, LLC $60.42 2022-2024 Xifaxan
Boston Scientific Corporation $56.30 2021-2025 Watchman Flx
Biohaven Pharmaceutical Holding Company LTD. $47.56 2022
Teleflex LLC $42.07 2022-2023 Urolift
Bayer Healthcare Pharmaceuticals INC. $40.68 2021-2024
Takeda Pharmaceuticals U.S.A., INC. $39.43 2021
Phathom Pharmaceuticals, INC. $37.74 2024 Voquezna
Viatris Specialty LLC $36.67 2025 Yupelri
Averitas Pharma INC. $26.18 2025 Qutenza
Sunovion Pharmaceuticals INC. $23.13 2021
Otsuka America Pharmaceutical, INC. $19.42 2023 Rexulti
Almatica Pharma LLC $18.42 2024 Loreev Xr
Coloplast Corp $18.13 2025
Sanofi Pasteur INC. $17.32 2021
Eisai INC. $16.28 2021
Azurity Pharmaceuticals, INC. $16.06 2025
Idorsia Pharmaceuticals US INC $15.85 2022
Lundbeck LLC $15.43 2025 Rexulti
Impulse Dynamics (USA) INC. $15.39 2023 Optimizer
Saluda Medical Americas, INC. $15.35 2024 Evoke
Vertos Medical, INC. $15.06 2023 Mild Device Kit
Amarin Pharma, INC. $14.40 2021

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Jared D Gunnell

$3,352.23

in general payments reported 2019-2025

Years
2021-2025
Top company
Abbvie INC.
Context
The $809 reported for 2025 was more than what 80% of Physician Assistant providers received nationally (typical 2025 total: $183).

https://glasscript.com/doctor/10903900/jared-d-gunnell

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.